Table 1.
Genetic Test Results of Patients
| Genes | Result | Concrete Result | Specific Value | Methodology |
|---|---|---|---|---|
| ALK | Negative | — | — | |
| BRAF | Negative | — | — | |
| EGFR | Negative | — | — | |
| ERB2 | Negative | — | — | |
| KRAS | Negative | — | — | NGS |
| MET | Negative | — | — | |
| RET | Negative | — | — | |
| ROS1 | Negative | — | — | |
| MSI | MSS | — | — | |
| TP53 | Positive | c.641_644delinsTp.His214_Ser215delinsLeu | 7.92% |
Note: Genetic testing was performed using next-generation sequencing (NGS).
Abbreviations: ALK, anaplastic lymphoma kinase; BRAF, This gene is located on human chromosome 7 (NC_000007.14 (140719327.140924928, complement))and encodes the serine/threonine protein kinase of the RAF family; EGFR, epidermal growth factor receptor; ERBB2, receptor tyrosine kinase 2; KRAS, Kirsten-rous avian sarcoma; MET, This gene is located on chromosome 7q21-q31, and its encoded met protein belongs to tyrosine kinase receptor; RET, RET proto-oncogene; ROS1, ROS proto-oncogene 1 receptor tyrosine kinase; MSI, microsatellite instability; MSS, microsatellite stable; TP53, Tumor Protein P53.